Capital Genomix and Blanchette Rockefeller Neurosciences Institute to Build Array Facility
Capital Genomix and the Blanchette Rockefeller Neurosciences Institute plan to establish a microarray core facility.
The space, to be housed at Johns Hopkins University's Shady Grove campus in Gaithersburg, Md., will be headed by microarray researcher Pachiappan Manickam.
Capital, based in Chantilly, Va., holds a microarray service license from Affymetrix.
The company said the collaboration with BRNI, a non-profit institute focusing on translational research in the area of Alzheimer's disease, will expand to include its own gene-expression and antibody technologies. They are called GeneSystem320 and ImmunoMouse, respectively.
Orchid Biosciences, Genetic Technologies Swap Licenses
Orchid BioSciences and Genetic Technologies have licensed each other's technologies.
Genetic Technologies, of Melbourne, Australia, obtained exclusive licenses to Orchid's SNP panels for paternity and forensic DNA testing services, as well as to its Elucigene diagnostic kits for use in Australia, New Zealand, and Southeast Asia. The firm has also acquired a non-exclusive license to primer extension patents held by Orchid.
Orchid, meantime, will receive royalties from revenues that Genetic Technologies will generate using these technologies. Orchid also receives an option to license Genetic Technologies' non-coding patents for SNP analysis, as well as clearance for past business activities that may have been covered by these patents, the companies said.
French Cancer Institute Adds Gene Expression Training, Services Center
The Institut Gustave-Roussy, France's largest cancer research center, will provide genomics research services for the European scientific community.
In addition, the nonprofit IGR said it will use a microarray platform made by Agilent together with Rosetta's Resolver bioinformatics system to develop cancer diagnostic tools and services.
Michigan Life Sciences Corridor To get $30 Million in Funding
The Michigan Life Sciences Corridor will receive $30 million in funding for 2004.
While the funding will be less than the $45 million originally earmarked for life science R&D in a corridor stretching from Detroit to Grand Rapids and Kalamazoo, it is not as small as the $20 million Gov. Jennifer Granholm had originally proposed in a budget-slashing response to the state's fiscal crisis.
The funds are being disbursed from $1 billion in tobacco settlement money.
The corridor is a 20-year initiative launched in 1999 to boost the state's life sciences industry.
Additionally, the Michigan Life Sciences Corridor steering committee authorized the creation of a $2 million emergency fund to assist Pfizer scientists and professionals laid off after the company’s acquisition of Pharmacia last month.
University of Leipzig Opts for Insightful Microarray Solution
Insightful said that the University of Leipzig has selected its microarray data-analysis system.
The S+ArrayAnalyzer is a Internet-based system for sharing and analyzing microarray data.
Financial details were not provided.
BioExpress Subscribes to Gene Logic’s BioExpress Platform
Belgian drug maker Solvay Pharmaceuticals has subscribed to Gene Logic’s BioExpress system for drug target-discovery research.
Gene Logic, of of Gaithersburg, Md., also said that Wyeth had renewed its subscription to the database of gene-expression information.
TGen to Study Diabetes In Pima Indian Population
The Translational Genomics Research Institute will partner with the Salt River Pima-Maricopa Indian community and the city of Phoenix to study the genetic basis of diabetes.
In a ceremony at TGen's Phoenix headquarters last week, the Salt River Community and the city committed to provide $1 million a year to support the project for a five-year period.
The Salt River Pima-Maricopa Indian community is located on 53,600 acres of Maricopa County, Ariz., with a population of more than 7,000 enrolled community members. Pima Indians are known to have a high rate of the disease.